CoChat

In Vitro Secretion of Cytokines by Human Bone Marrow: Effects of Age and Estrogen Status1

Cheleuitte, Domingo, Mizuno, Shuichi, Glowacki, Julie · 1998 · The Journal of Clinical Endocrinology & Metabolism
Cited by 127

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

It has been proposed that cytokines mediate the acceleration of bone loss following menopause. Because of the intimate relationship between bone marrow stromal cells and bone tissue, it is possible that marrow cells and their products contribute to the bone microenvironment and influence the regulation of bone cell differentiation and activity. We examined the production of cytokines by bone marrow stromal cells from a total of 37 women and 15 men undergoing total hip replacement for noninflammatory joint disease. Low-density mononuclear cells were isolated from bone marrow and were cultured in phenol red-free αMEM medium supplemented with 10% FBS and antibiotics. Constitutive secretion of interleukin-6 (IL-6) was positively correlated with age in a series of 8 women and 5 men measured by bioassay (r = 0.98; P < 0.01) and in a series of 18 women and 10 men measured by immunoassay (r = 0.56; P < 0.01). The pattern of cytokine production by bone marrow stromal cells was examined in detail in 23 postmenopausal women, aged 49–88 yr. Basal secretion of immunoreactive IL-6 and IL-11, but not granulocyte-macrophage colony-stimulating factor, increased with time in culture. Exogenous IL-1β stimulated secretion of IL-6 and IL-11 in a saturable, dose-dependent manner. Secretion of soluble IL-6 receptor was not correlated with secretion of IL-6, either constitutively or in the presence of IL-1β. In 4 of 14 samples, IL-1β also stimulated secretion of granulocyte-macrophage colony-stimulating factor. IL-1β was undetectable in 7 of 9 cultures during the 2-week culture period. IL-6 did not stimulate secretion of IL-1β in the 7 cultures tested. Cells were dependent upon serum for viability and growth and were not sustained by a serum substitute (1% insulin-transferrin-selenium-BSA). Cells grown in medium with 10% FBS and supplemented with 1% insulin-transferrin-selenium-BSA secreted 10-fold more IL-6 than cells grown in serum alone. Marrow from 7 women receiving estrogen replacement therapy showed lower constitutive secretion of IL-6 (75%; P < 0.006) and IL-11 (43%; P< 0.05) than marrow from age-matched controls and had blunted stimulation of IL-6 and IL-11 secretion by exogenous IL-1β. These data indicate distinct patterns of cytokine production by human marrow stromal cultures dependent upon age and estrogen status.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.83.6.4848

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 29

  1. Manolagas, 1995, Bone marrow, cytokines, and bone remodeling., N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 · DOI · Paper page
  2. 1993, Cytokines and estrogen in bone: anti-osteoporotic effects., Science, 260, 626, 10.1126/science.8480174 · DOI · Paper page
  3. Bot, 1989, Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells., Blood, 73, 435, 10.1182/blood.V73.2.435.435 · DOI
  4. Caracciolo, 1989, Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF., Blood, 73, 666, 10.1182/blood.V73.3.666.666 · DOI · Paper page
  5. 1992, Effect of interleukin-11 on cycling status and clonogenic maturation of fetal and adult hematopoietic progenitors., Blood, 80, 900, 10.1182/blood.V80.4.900.900 · doi:10.1182/blood.v80.4.900.900
  6. Kotake, 1996, Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation., J Bone Miner Res, 11, 88, 10.1002/jbmr.5650110113 · DOI · Paper page
  7. Fibbe, 1988, Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulatung factor., Blood, 71, 430, 10.1182/blood.V71.2.430.430 · DOI · Paper page
  8. Caldwell, 1994, IL-1α and TNFα act synergistically to stimulate production of myeloid colony-stimulating factors by cultured human bone marrow stromal cells and cloned stromal cell strains., J Cell Physiol, 159, 221, 10.1002/jcp.1041590205 · DOI
  9. Yang, 1988, Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts., J Cell Physiol, 134, 292, 10.1002/jcp.1041340217 · DOI
  10. Neumanitis, 1989, Human marrow stromal cells: response to interleukin-6 (IL-6) and control of IL-6 expression., Blood, 74, 1929, 10.1182/blood.V74.6.1929.1929 · DOI
  11. Guba, 1992, Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction., Blood, 80, 1190, 10.1182/blood.V80.5.1190.1190 · DOI
  12. Kurihara, 1990, IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release., J Immunol, 144, 4226, 10.4049/jimmunol.144.11.4226 · DOI · Paper page
  13. Schaafsma, 1989, Interleukin-6 is not involved in the interleukin-1-induced production of colony-stimulating factors by human bone marrow stromal cells and fibroblasts., Blood, 74, 2619, 10.1182/blood.V74.8.2619.2619 · doi:10.1182/blood.v74.8.2619.2619
  14. Rifas, 1995, Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids., Endocrinology, 136, 4056, 10.1210/endo.136.9.7649114 · doi:10.1210/endo.136.9.7649114 · Paper page
  15. Girasole, 1992, 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens., J Clin Invest, 89, 883, 10.1172/JCI115668 · DOI · Paper page
  16. Kassem, 1996, Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors., J Bone Miner Res, 11, 193, 10.1002/jbmr.5650110208 · DOI · Paper page
  17. West, 1985, Asimplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells., Anal Biochem, 147, 289, 10.1016/0003-2697(85)90274-X · DOI · Paper page
  18. Long, 1989, Expression of human bone-related proteins in the hematopoietic microenvironment., J Clin Invest, 86, 1387, 10.1172/JCI114852 · DOI
  19. Jilka, 1992, Increased osteoclast development after estrogen loss: mediation by interleukin-6., Science, 257, 88, 10.1126/science.1621100 · DOI · Paper page
  20. Miyaura, 1995, Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6., J Bone Miner Res, 10, 1365, 10.1002/jbmr.5650100914 · DOI · Paper page
  21. Kitazawa, 1994, Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice., J Clin Invest, 94, 2397, 10.1172/JCI117606 · DOI · Paper page
  22. Girasole, 1994, Interleukin-11: a new cytokine critical for osteoclast development., J Clin Invest, 93, 1516, 10.1172/JCI117130 · DOI · Paper page
  23. Cohen-Solal, 1995, Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study., J Bone Miner Res, 10, 307, 10.1002/jbmr.5650100219 · DOI
  24. Cohen-Solal, 1998, Cytokine release from marrow mononuclear cells in negatively correlated to cortical elasticity in non-osteoporotic postmenopausal women., Calcif Tissue Int, 62, 13, 10.1007/s002239900386 · DOI
  25. Bismar, 1995, Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement., J Clin Endocrinol Metab, 80, 3351
  26. Lansdorp, 1992, Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow., J Exp Med, 175, 1501, 10.1084/jem.175.6.1501 · DOI · Paper page
  27. Klein, 1989, Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6., Blood, 73, 517, 10.1182/blood.V73.2.517.517 · DOI · Paper page
  28. Takahashi, 1995, Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation., Endocrinology, 136, 1441, 10.1210/endo.136.4.7534699 · DOI
  29. Rosen, 1997, Effects of age and estrogen status on the skeletal IGF regulatory system: studies with human marrow., Endocrine, 7, 77, 10.1007/BF02778068 · doi:10.1007/bf02778068

Cited by

Metadata

Authors
Cheleuitte, D., Mizuno, S., & Glowacki, J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1998-06-01
Volume
83
Issue
6
Pages
2043-2051
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2133857939
Cited by
127
References
1
FWCI
3.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.